05 Jun 2026
RSMR fund ratings are more than just a badge of quality — they represent trust, due diligence, and a reputation built on rigorous research and expert analysis. Every month we study the universe of funds in the investment marketplace to assess whether they meet our exacting standards and should be given the RSMR seal of approval.
Here are the new rated funds from our May review:
The Credo Dynamic Fund aims to deliver attractive long-term risk-adjusted returns through a diversified portfolio of global equities, fixed income and alternative investments, while maintaining a focus on capital preservation and downside protection. The fund follows a flexible multi-asset approach, allowing the managers to adjust asset allocation and overall portfolio risk as market conditions evolve. A core-and-satellite framework combines longer-term diversified holdings with more tactical investments designed to take advantage of valuation opportunities, changing market conditions and differentiated sources of return. Fixed income is implemented primarily through direct corporate bond selection, while alternatives such as infrastructure, renewable energy and commodities provide additional diversification and lowly correlated return streams.
RSMR has rated the fund in recognition of its flexible and actively managed multi-asset approach, supported by an experienced and agile investment team. The fund benefits from broad diversification across asset classes and a differentiated investment process that combines bottom-up security selection with macroeconomic awareness. The team's longstanding credit capabilities are an important differentiator, allowing the fund to build much of its bond exposure directly rather than relying solely on external managers. The portfolio's dynamic allocation framework, combined with a strong valuation discipline and active risk management, creates a distinctive proposition for investors seeking equity-like returns over the long term with lower downside risk than a traditional equity-focused strategy.
Click here to read the factsheet for the Credo Dynamic (Offshore) fund
The L&G Global Technology Index Fund provides investors with low-cost exposure to a diversified range of global technology companies through a passive investment approach. The fund tracks the FTSE World Technology Index, which includes large and mid-cap technology businesses across developed and emerging markets. Using physical replication, the portfolio aims to closely match the performance of the index while providing access to long-term growth themes such as digital transformation, artificial intelligence and technological innovation. The index's methodology results in significant exposure to established technology leaders, reflecting the market-cap weighted nature of the sector.
RSMR has rated the fund recognising LGIM's longstanding expertise in index management and its pragmatic approach to index replication. Rather than mechanically replicating every benchmark change, the team seeks to manage implementation efficiently, helping to reduce transaction costs while maintaining close alignment with the underlying index. The fund offers a simple and cost-effective way to access global technology equities, supported by a robust index management process and broad exposure to companies positioned to benefit from ongoing technological advancement.
Click here to read the factsheet for the L&G Global Technology Index fund
The L&G Global Healthcare & Pharmaceutical Index Fund provides investors with low-cost exposure to a diversified range of healthcare, pharmaceutical and biotechnology companies through a passive investment approach. The fund tracks the FTSE World Health Care Index, which includes large and mid-cap healthcare businesses across developed and emerging markets. Using physical replication, the portfolio aims to closely match the performance of the index while providing access to long-term structural growth themes such as ageing populations, rising healthcare demand and ongoing medical innovation. The sector’s defensive characteristics can also help provide resilience during periods of market uncertainty, compared with broader equity markets.
RSMR has rated the fund recognising LGIM’s longstanding expertise in index management and its pragmatic approach to index replication. Rather than seeking to replicate every benchmark change mechanically, the team focuses on efficient implementation designed to minimise transaction costs while maintaining close alignment with the underlying index. The fund offers a simple and cost-effective way to access global healthcare equities, supported by a robust index management process and broad exposure to companies benefiting from long-term trends across healthcare, pharmaceuticals and biotechnology.
Click here to read the factsheet for the L&G Global Health & Pharmaceuticals Index fund
The Fidelity Multi Asset Allocator fund range aims to provide capital growth over the long term by investing in a globally diverse range of assets classes. Each fund in the range provides a clear risk and return profile and the funds are managed to a set of long-term strategic asset allocations, as defined by Fidelity. The funds are globally diversified, investing in a combination of UK and global equities, global government and investment grade corporate bonds and global REITs. The funds invest in passive vehicles including ETFs, using a combination of Fidelity in-house funds and third-party providers.
The Fidelity Multi Asset Allocator funds are managed by an experienced team, supported by the strong research capabilities at Fidelity. Whilst the strategic asset allocation is the key driver of returns, the open architecture approach in their underlying passive exposure does differentiate the Allocator range from many of their peer group and Fidelity place a great deal of resource and effort in selecting the most appropriate security for underlying exposure. The Fidelity Multi Asset Allocator funds are a good option for investors seeking a straightforward, low-cost range of solutions, offering a choice of five clearly defined risk profiles.
Click here to read the factsheet for the Fidelity Multi-Asset Allocator fund range
RSMR provides impartial, qualitative, forward-looking research for advice businesses.
Click here to find out more about RSMR research and to access RSMR fund ratings, fund profiles, factsheets, insights, market updates and event information.
This information is for UK Professional Advisers only and should not be given to retail clients.
The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested.